{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:30:54Z","timestamp":1791945054875,"version":"4.3.4"},"reference-count":51,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Chlamydia trachomatis is the most frequently-notified sexually transmitted infection in Australia. Effective and timely partner treatment of chlamydia is essential to reduce overall prevalence and the burden of infection. Currently in most of Australia, the only avenue for partner treatment of chlamydia (\u201cstandard partner therapy\u201d) is a tedious, and often inconvenient, process. The barriers and facilitators of standard partner therapy, and newer models of accelerated partner therapy (APT), need to be identified in the Australian setting. Additionally, the potential role of community pharmacists need to be explored. Semi-structured interview guides for two key stakeholder groups (prescribers and pharmacists) were developed and piloted. Eleven prescribers (general practitioners, sexual health clinicians and nurse practitioners) and twelve pharmacists practicing in the Perth metropolitan region were interviewed. Key reported barriers to standard partner therapy were lack of or delayed chlamydia testing. Key facilitators included ability to test and educate sexual partner. Key barriers for APT included prescribers\u2019 legal responsibility and potential for medication-related adverse effects. Healthcare provider consultation and chlamydia testing were seen as potential facilitators of APT. Pharmacists were receptive to the idea of expanding their role in chlamydia treatment, however, barriers to privacy must be overcome in order to be acceptable to prescribers and pharmacists.<\/jats:p>","DOI":"10.3390\/pharmacy6010017","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:46:27Z","timestamp":1518180387000},"page":"17","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Barriers and Facilitators of Partner Treatment of Chlamydia: A Qualitative Investigation with Prescribers and Community Pharmacists"],"prefix":"10.3390","volume":"6","author":[{"given":"Helen","family":"Wood","sequence":"first","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hall","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ioppolo","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Ioppolo","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Scacchia","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Clifford","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajni","family":"Gudka","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, School of Allied Health, The University of Western Australia, Perth 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"ref_1","unstructured":"Australian Government Department of Health (2018, May 11). National Notifiable Diseases Surveillance Systems, Available online: http:\/\/www9.health.gov.au\/cda\/source\/rpt_2.cfm."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lallemand, A., Bremer, V., Jansen, K., Nielsen, S., M\u00fcnstermann, D., Lucht, A., and Tiemann, C. (2016). Prevalence of chlamydia trachomatis infection in women, heterosexual men and MSM visiting HIV counselling institutions in North Rhine-Westphalia, Germany-should chlamydia testing be scaled up?. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1915-2"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/14647273.2010.513893","article-title":"Impact of chlamydia trachomatis in the reproductive setting: British fertility society guidelines for practice","volume":"13","author":"Akande","year":"2010","journal-title":"Hum. Fertil."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00007435-200301000-00011","article-title":"Patient-delivered partner treatment with azithromycin to prevent repeated chlamydia trachomatis infection among women: A randomized, controlled trial","volume":"30","author":"Schillinger","year":"2003","journal-title":"Sex. Transm. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/648734","article-title":"Repeated chlamydia trachomatis genital infections in adolescent women","volume":"201","author":"Batteiger","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00007435-200209000-00005","article-title":"Behaviors changed by intervention are associated with reduced STD recurrence: The importance of context in measurement","volume":"29","author":"Shain","year":"2002","journal-title":"Sex. Transm. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-8-62","article-title":"Take the sex out of STI screening! Views of young women on implementing chlamydia screening in general practice","volume":"8","author":"Pavlin","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1071\/SH12019","article-title":"What do young women think about having a chlamydia test? Views of women who tested positive compared with women who tested negative","volume":"10","author":"Walker","year":"2013","journal-title":"Sex. Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1054-139X(03)00303-3","article-title":"Young adults\u2019 attitudes, beliefs, and feelings about testing for curable STDs outside of clinic settings","volume":"34","author":"Ford","year":"2004","journal-title":"J. Adolesc. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-4-21","article-title":"Barriers to asymptomatic screening and other STD services for adolescents and young adults: Focus group discussions","volume":"4","author":"Tilson","year":"2004","journal-title":"BMC Public Health"},{"key":"ref_12","first-page":"33","article-title":"\u201cIf everyone does it, it\u2019s not a big deal.\u201d Young people talk about chlamydia testing","volume":"121","author":"Rose","year":"2008","journal-title":"N. Z. Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hogan, A.H., Howell-Jones, R.S., Pottinger, E., Wallace, L.M., and McNulty, C.A. (2010). \u201c\u2026 They should be offering it\u201d: A qualitative study to investigate young peoples\u2019 attitudes towards chlamydia screening in GP surgeries. BMC Public Health, 10.","DOI":"10.1186\/1471-2458-10-616"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13698571003632437","article-title":"Why don\u2019t young women go for chlamydia testing? A qualitative study employing Goffman\u2019s stigma framework","volume":"12","author":"Balfe","year":"2010","journal-title":"Health Risk Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jpag.2007.08.009","article-title":"Young women\u2019s perspective of the pros and cons to seeking screening for chlamydia and gonorrhea: An exploratory study","volume":"21","author":"Chacko","year":"2008","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/sti.2010.047258","article-title":"Can we improve partner notification rates through expedited partner therapy in the UK? Findings from an exploratory trial of Accelerated Partner Therapy (APT)","volume":"88","author":"Estcourt","year":"2012","journal-title":"Sex. Transm. Infect."},{"key":"ref_17","unstructured":"Department of Health (Northern Territory) (2016, April 11). Patient Delivered Partner Therapy Guidelines, Available online: http:\/\/www.health.nt.gov.au\/library\/scripts\/objectifyMedia.aspx?file=pdf\/94\/33.pdf&siteID=1&str_title=Patient%20Delivered%20Partner%20Therapy%20Guidelines.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/sti.74.5.331","article-title":"Effectiveness of patient delivered partner medication for preventing recurrent chlamydia trachomatis","volume":"74","author":"Kissinger","year":"1998","journal-title":"Sex. Transm. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1471-0528.2008.01971.x","article-title":"Patient-delivered partner therapy for chlamydia\u2014A realistic public health measure in the UK","volume":"116","author":"Cameron","year":"2009","journal-title":"BJOG"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1471-0528.2010.02573.x","article-title":"Expedited partner therapy for chlamydia trachomatis at the community pharmacy","volume":"117","author":"Cameron","year":"2010","journal-title":"BJOG"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/OLQ.0b013e31827adc06","article-title":"Acceptability and intention to seek medical care after hypothetical receipt of patient-delivered partner therapy or electronic partner notification postcards among men who have sex with men: The partner\u2019s perspective","volume":"40","author":"Kerani","year":"2013","journal-title":"Sex. Transm. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1258\/ijsa.2008.008003","article-title":"Patient-delivered partner therapy in the UK: What do the professionals think?","volume":"19","author":"Shivasankar","year":"2008","journal-title":"Int. J. STD AIDS"},{"key":"ref_23","unstructured":"Victorian State Government (2016, April 11). Patient Delivered Partner Therapy Clinical Guidelines, Available online: https:\/\/www2.health.vic.gov.au\/about\/publications\/policiesandguidelines\/pdpt-clinical-guidelines."},{"key":"ref_24","unstructured":"Healthdirect (2017, November 21). Australia\u2019s Healthcare System, Available online: https:\/\/www.healthdirect.gov.au\/australias-healthcare-system."},{"key":"ref_25","unstructured":"InterNations (2017, October 01). Moving to Perth. Available online: https:\/\/www.internations.org\/perth-expats\/guide\/moving-to-perth-15654."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wakerman, J., Humphreys, J.S., Wells, R., Kuipers, P., Entwistle, P., and Jones, J. (2008). Primary health care delivery models in rural and remote Australia\u2014A systematic review. BMC Health Serv. Res., 8.","DOI":"10.1186\/1472-6963-8-276"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1098214005283748","article-title":"A general inductive approach for analyzing qualitative evaluation data","volume":"27","author":"Thomas","year":"2006","journal-title":"Am. J. Eval."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bryman, A., and Burgess, R.G. (1994). Qualitative data analysis for applied policy research. Analyzing Qualitative Data, Routledge.","DOI":"10.4324\/9780203413081_chapter_11"},{"key":"ref_29","first-page":"508","article-title":"Barriers to opportunistic chlamydia testing in primary care","volume":"54","author":"McNulty","year":"2004","journal-title":"Br. J. Gen. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lorch, R., Hocking, J., Temple-Smith, M., Law, M., Yeung, A., Wood, A., Vaisey, A., Donovan, B., Fairley, C.K., and Kaldor, J. (2013). The chlamydia knowledge, awareness and testing practices of Australian general practitioners and practice nurses: Survey findings from the Australian Chlamydia Control Effectiveness Pilot (ACCEPt). BMC Fam. Pract., 14.","DOI":"10.1186\/1471-2296-14-169"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lorch, R., Hocking, J., Guy, R., Vaisey, A., Wood, A., Lewis, D., and Temple-Smith, M. (2015). Practice nurse chlamydia testing in australian general practice: A qualitative study of benefits, barriers and facilitators. BMC Fam. Pract., 16.","DOI":"10.1186\/s12875-015-0251-8"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Pavlin, N.L., Parker, R.M., Piggin, A.K., Hopkins, C.A., Temple-Smith, M.J., Fairley, C.K., Tomnay, J.E., Bowden, F.J., Russell, D.B., and Hocking, J.S. (2010). Better than nothing? Patient-delivered partner therapy and partner notification for chlamydia: The views of Australian general practitioners. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-274"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hocking, J.S., Parker, R.M., Pavlin, N., Fairley, C.K., and Gunn, J.M. (2008). What needs to change to increase chlamydia screening in general practice in Australia? The views of general practitioners. BMC Public Health, 8.","DOI":"10.1186\/1471-2458-8-425"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1258\/095646207782716956","article-title":"Patient-delivered partner medication in the UK: An unlawful but popular choice","volume":"18","author":"Coyne","year":"2007","journal-title":"Int. J. STD AIDS"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/OLQ.0000000000000045","article-title":"Expedited partner therapy in federally qualified health centers\u2014New York City, 2012","volume":"40","author":"Introcaso","year":"2013","journal-title":"Sex. Transm. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/OLQ.0b013e31818eb73c","article-title":"Alternative approaches to partner notification, diagnosis, and treatment: Pharmacists\u2019 perspectives on proposed patient delivered partner therapy in New York State, 2007","volume":"36","author":"McNutt","year":"2009","journal-title":"Sex. Transm. Dis."},{"key":"ref_37","unstructured":"Mooney-Somers, J., Micallef, J., Bateson, D., Harvey, C., Van Gemert, C., Lewis, L., Kaldor, J., and Guy, R. (2013, January 21\u201323). Patient Delivered Partner Therapy for Chlamydia: Support and Concern among Doctors and Nurses Working in Australian Family Planning Clinics. Proceedings of the Sexual Health Conference, Darwin, Australia. Available online: https:\/\/ses.library.usyd.edu.au\/handle\/2123\/11976."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/OLQ.0b013e31820cb206","article-title":"A qualitative study of patients\u2019 use of expedited partner therapy","volume":"38","author":"Temkin","year":"2011","journal-title":"Sex. Transm. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2010.07.011","article-title":"Emergency contraception in Australian community pharmacies: A simulated patient study","volume":"83","author":"Queddeng","year":"2011","journal-title":"Contraception"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sapharm.2012.03.004","article-title":"Requests for emergency contraception in community pharmacy: An evaluation of services provided to mystery patients","volume":"9","author":"Higgins","year":"2013","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.contraception.2010.07.001","article-title":"Provision of the emergency contraceptive pill without prescription: Attitudes and practices of pharmacists in Australia","volume":"83","author":"Hussainy","year":"2011","journal-title":"Contraception"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection","volume":"352","author":"Golden","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/humrep\/den475","article-title":"Novel interventions to reduce re-infection in women with chlamydia: A randomized controlled trial","volume":"24","author":"Cameron","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.olq.0000161089.53411.cb","article-title":"The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: Implications for partner notification and treatment","volume":"32","author":"Khan","year":"2005","journal-title":"Sex. Transm. Dis."},{"key":"ref_45","unstructured":"Bixby Center for Global Reproductive Health (2017, October 12). Does Emergency Contraception Promote Sexual Risk-Taking?. Available online: https:\/\/bixbycenter.ucsf.edu\/sites\/bixbycenter.ucsf.edu\/files\/DoesECPromoteSexRiskTaking_2008.pdf."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/j.2055-2335.2007.tb00767.x","article-title":"Acceptance of a chlamydia screening program in community pharmacies","volume":"37","author":"Taylor","year":"2007","journal-title":"J. Pharm. Pract. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e003338","DOI":"10.1136\/bmjopen-2013-003338","article-title":"To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia","volume":"3","author":"Gudka","year":"2013","journal-title":"BMJ Open"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1471-0528.2007.01506.x","article-title":"Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with chlamydia","volume":"114","author":"Cameron","year":"2007","journal-title":"BJOG"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/0956462415610689","article-title":"Perspectives on expedited partner therapy for chlamydia: A survey of health care providers","volume":"27","author":"Rosenfeld","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/sextrans-2014-051873","article-title":"Healthcare providers\u2019 perspectives on expedited partner therapy for chlamydia: A qualitative study","volume":"91","author":"Rosenfeld","year":"2015","journal-title":"Sex. Transm. Infect."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1071\/SH10031","article-title":"Is accelerated partner therapy partner notification for sexually transmissible infections acceptable and feasible in general practice?","volume":"8","author":"Shackleton","year":"2011","journal-title":"Sex. Health"}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/6\/1\/17\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:54:20Z","timestamp":1760194460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/6\/1\/17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["pharmacy6010017"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy6010017","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]}}}